Eloxx Pharmaceuticals, Inc (ELOX) insider trading
Every open-market stock purchase and sale by Eloxx Pharmaceuticals, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- No open-market insider trades in the last 12 months.
- Last insider buy: Daniel E. Geffken (CFO), $36K, 4 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales).
Recent ELOX insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jun 10, 2026 | Sumit Aggarwal (CEO) | Bought (not open market) | — |
| Jun 10, 2026 | Domicilium Real Estate Fund III LP (10% owner) | Bought (not open market) | — |
| Jun 10, 2026 | Domicilium Real Estate Fund III LP (10% owner) | Bought (not open market) | — |
| Jun 8, 2026 | Steven D Rubin (Insider) | Bought (not open market) | — |
| Jun 8, 2026 | Nina S Kjellson (Insider) | Bought (not open market) | — |
| Jun 8, 2026 | Alan Edmund Walts (Insider) | Bought (not open market) | — |
| Jun 8, 2026 | Stephen W Webster (Insider) | Bought (not open market) | — |
| May 27, 2026 | Coastlands Capital LP (10% owner) | Bought (not open market) | — |
| May 27, 2026 | Domicilium Real Estate Fund III LP (10% owner) | Bought (not open market) | — |
| Feb 28, 2026 | Sumit Aggarwal (CEO) | Bought (not open market) | — |
| Jan 24, 2026 | Alan Edmund Walts (Insider) | Bought (not open market) | — |
| Jan 24, 2026 | Sumit Aggarwal (CEO) | Bought (not open market) | — |
| Jan 24, 2026 | Steven D Rubin (Insider) | Bought (not open market) | — |
Who's trading ELOX
- Domicilium Real Estate Fund III LP, 10% owner: other filings, last Jun 10, 2026
- Sumit Aggarwal, CEO: other filings, last Jun 10, 2026
- Stephen W Webster, Insider: other filings, last Jun 8, 2026
- Steven D Rubin, Director: other filings, last Jun 8, 2026
- Alan Edmund Walts, Director: other filings, last Jun 8, 2026
- Nina S Kjellson, Insider: other filings, last Jun 8, 2026
- Coastlands Capital LP, 10% owner: other filings, last May 27, 2026
Get free alerts when an insider at Eloxx Pharmaceuticals, Inc files a new trade →